Hydrofarm Holdings Group, Inc. HYFM Q3 2022 net sales decreased 40% to $74.2 million compared to $123.8 million in Q3 2021.
Q3 2022 Highlights vs. Q3 2021
-
Gross profit decreased to $5.9 million, or 7.9% of sales, during the third quarter of 2022 compared to $30.0 million, or 24.2% of sales in the prior year.
-
Net loss was $(23.5) million, or $(0.52) per diluted share, compared to net income of $17.3 million, or $0.37 per diluted share.
-
Adjusted EBITDA was $(9.0) million, or (12.2)% of net sales, for the third quarter of 2022, compared to $16.1 million, or 13.0% of net sales, in the third quarter of 2021.
Reaffirming Full Year 2022 Outlook:
-
Net sales of approximately $330 million to $347 million.
-
Adjusted EBITDA of approximately $(25) million to $(16) million.
Bill Toler, chairman and CEO of Hydrofarm, stated, “While our third quarter results were below last year due to the persistent and well acknowledged industry recession, our underlying performance was generally in-line with our internal expectations. Moreover, our strong cash flow from operating activities exceeded our expectations as we generated positive free cash flow for the second quarter in a row. Together, these results demonstrate our ability to navigate the challenging operating environment while the broader industry finds its way through supply/demand imbalances, and as such, we are reaffirming our full year 2022 outlook ranges for net sales and Adjusted EBITDA."
Balance Sheet and Liquidity
As of September 30, 2022, the company had $16.5 million in cash and an aggregate principal amount of debt outstanding of $126.3 million which consisted of approximately $124.1 million in principal balance on its term loan and approximately $2.2 million in finance leases and other debt.
Price Action
Hydrofarm shares were trading 11.11% higher at $2.3 during Thursday’s pre-market session.
Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.
Photo by Giorgio Trovato on Unsplash
Related News
Great Elm Group And 3 Other Stocks Under $5 Insiders Are Aggressively Buying
Diversification For The Future? How iPower Hopes To Fill Value Gaps In The Marketplace
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.